180 Life Sciences Corp Earnings

The next earnings date for 180 Life Sciences Corp has not yet been scheduled.

Analyst Estimates of 180 Life Sciences Corp Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

180 Life Sciences Corp Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/13/2025After Market------
03/20/2025After Market------
11/07/2024After Market$-0.85---
08/12/2024After Market$0.01---
05/15/2024After Market$-1.68---
03/25/2024Before Market$-26.60-800.00%
11/09/2023After Market$-1.29---
08/15/2023After Market$-0.70---
05/15/2023After Market$-1.27---
03/31/2023After Market$-10.89-9,800.64%
11/10/2022After Market$-1.40-800.00%
08/09/2022After Market$1.80169.23%
05/16/2022Before Market$1138.46%
03/31/2022Before Market$1138.46%
11/15/2021Before Market$-2.208.33%
08/16/2021After Market$-0.17---
06/30/2021---$-0.75---
03/31/2021---$-0.58---
11/24/2020---$-0.36---
08/20/2020---$-0.52---
04/07/2020---$-0.07---
03/31/2020---$-0.14---
11/12/2019---$-0.01---
09/30/2019---$-0.01---
06/30/2019---$-0.00---
03/31/2019---$0.01---
12/31/2018---$-410.19---

More About 180 Life Sciences Corp

Website
https://180lifesciences.com
Country
USA
Full Time Employees
0

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

“180 Life Sciences Corp Earnings” Can Refer to the 180 Life Sciences Corp Earnings Date

Some people say “180 Life Sciences Corp earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my 180 Life Sciences Corp position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning 180 Life Sciences Corp Stock on the Earnings Date

If you own 180 Life Sciences Corp stock (ATNF) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for 180 Life Sciences Corp might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading 180 Life Sciences Corp shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More 180 Life Sciences Corp Earnings

You can contact us any time if you would like to ask questions about 180 Life Sciences Corp earnings or anything else related to the stock market.